News - Unibest Industrial Co., Ltd.

Blogs

Welcome to Unibest's Blogs section! Here, you will find valuable insights and in-depth reports covering various topics related to drugs and diseases. Our blogs aim to provide an enhanced understanding of the clinical significance and breakthroughs your clients can make. Stay updated with the latest trends, technological advancements, and industry analyses as we dive deep into the world of pharmaceuticals, giving you the knowledge and resources you need to stay ahead of the competition.

Drug Briefing: Midazolam
2024-04-11

Query Drug：Midazolam Query Time：2024-04-17 10:20:21 Read More
Drug Briefing: Semaglutide
2024-04-11

Query Drug：SemaglutideQuery Time：2024-08-26 09:30:00*** Disclaimer *** The information provided here is sourced from resources such as Drugs.com, the Orange Book, etc., and is auto-generated by the Unibest Digital Center. The content is intended exclusively for pharmaceutical professionals. Unibest Read More
The Melt-In-Your-Mouth Medicine
2024-03-01

Why Choose Orally Dissolving Tablets (ODTs)?Orally dissolving tablets (ODTs) have revolutionized the pharmaceutical industry and patient care by enhancing drug life-cycle management and offering convenient dosing for patients who have difficulty swallowing, such as children, the elderly, and psychia Read More
Cancer, radiopharma & RDCs
2024-02-27

Market potential of radiopharma & RDCsRDCs are currently being developed for cancer. According to the WHO IARC, in 2022, the five most common cancers resulted in 19,956,054 new cases and 9,736,520 deaths. It is estimated that by 2050, the incidence of all cancers will reach 35.3 million. Consequentl Read More
Stability of Pharmaceutical Industry Supply Chains Against the Backdrop of Deglobalization
2024-02-23

In the tide of globalization, supply chains, as the important link connecting the economies of various countries, play an extremely important role. However, in recent years, the trend of deglobalization has gradually emerged, bringing unprecedented challenges to global supply chains. Especially in t Read More
Radionuclide Drug Conjugates (RDC): A New Star in Precision Medicine
2024-02-08

In today's pharmaceutical industry, an innovative therapeutic known as "Radionuclide Drug Conjugates" (RDC) is gradually making its mark. In the 2023 FDA's approval, there is one drug called flotufolastat F-18 (Posluma). It is an intravenous binder to PSMA expressed on cells for PET imaging of prost Read More
Seizing the Opportunity in the CGRP Targeting Drugs Market
2024-02-04

The global pharmaceutical landscape is witnessing a remarkable surge in the development and approval of drugs targeting trigeminal neuropeptide calcitonin gene-related peptide (CGRP) or its receptor, especially for treating migraine, a debilitating neurological disorder affecting a substantial adult Read More
The Magic Bullet in the Synthesis? - Well, Name Goes to the Molecular Building Blocks
2024-01-24

Molecular building blocks, also known as organic building blocks, are functionalized molecules that serve as the foundational components for organic synthesis. Utilized for bottom-up modular assembly, they enable the construction of molecular architectures such as supramolecular complexes, metal-org Read More
Two Decades of Sustainable Development, a Message from the Founder
2024-01-19

Dear colleagues and families,Good evening!Today, we gather together to celebrate the 20th anniversary of Unibest.First and foremost, I want to express my deepest gratitude for your unwavering support and colossal contributions! It’s because of you all that Unibest has achieved every bit of success. Read More